Papers - FUJITA Naoki
-
Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases
Hiromichi Iwamura, Kei Mizuno, Shusuke Akamatsu, Shingo Hatakeyama, Yuki Tobisawa, Shintaro Narita, Takuma Narita, Shinichi Yamashita, Sadafumi Kawamura, Toshihiko Sakurai, Naoki Fujita, Hirotake Kodama, Daisuke Noro, Ikuko Kakizaki, Shigeyuki Nakaji, Ken Itoh, Norihiko Tsuchiya, Akihiro Ito, Tomonori Habuchi, Chikara Ohyama, Tohru Yoneyama
Cancer Science 2022.7
-
Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study
Naoki Fujita, Shingo Hatakeyama, Ryuji Tabata, Kazutaka Okita, Koichi Kido, Itsuto Hamano, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Yuichiro Suzuki, Takahiro Yoneyama, Yasuhiro Hashimoto, Satoshi Sato, Chikara Ohyama
Prostate International 2024.3
-
Association between oral frailty and lower urinary tract symptoms among middle-aged and older adults in community-dwelling individuals: a cross-sectional study
Fumiya Yoneyama, Teppei Okamoto, Yoshihiro Tamura, Noritaka Ishii, Kyo Togashi, Osamu Soma, Naoki Fujita, Hayato Yamamoto, Shingo Hatakeyama, Wataru Kobayashi, Chikara Ohyama
International Urology and Nephrology 2024.1
-
Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study
Yoshiharu Okuyama, Shingo Hatakeyama, Ryuji Tabata, Daiji Fujimori, Yohei Kawashima, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Kazuyuki Mori, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Toshimitsu Matsuoka, Satoshi Sato, Chikara Ohyama
International Journal of Urology 2023.8
-
Relationship between lower urinary tract symptoms and frailty
Yusuke Ozaki, Shingo Hatakeyama, Atsushi Imai, Jung Songee, Osamu Soma, Kai Ozaki, Naoki Fujita, Teppei Okamoto, Hiromichi Iwamura, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International Journal of Urology 2023.7
-
Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
World Journal of Men's Health 2023.4
-
Trends in the age of hospitalized patients with urological cancers: A 17-year experience
Noritaka Ishii, Shingo Hatakeyama, Hikari Miura, Ryuma Tanaka, Takuya Oishi, Hirotaka Horiguchi, Shogo Hosogoe, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International Journal of Urology 2023.3
-
Combination of Muscle Quantity and Quality Is Useful to Assess the Necessity of Surveillance after a 5-Year Cancer-Free Period in Patients Who Undergo Radical Cystectomy: A Multi-Institutional Retrospective Study
Naoki Fujita, Masaki Momota, Hirotaka Horiguchi, Itsuto Hamano, Jotaro Mikami, Shingo Hatakeyama, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Shoji Nishimura, Kazuaki Yoshikawa, Chikara Ohyama
Cancers (Basel) 2023.2
-
Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer
Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
PLoS One 2023.2
-
Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
Naoki Fujita, Masaki Momota, Yusuke Ozaki, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
World Journal of Men's Health 2023.1
-
Association between Advanced Glycation End-Products, Carotenoids, and Severe Erectile Dysfunction
Naoki Fujita, Mizuri Ishida, Takuro Iwane, Hiroyuki Suganuma, Mai Matsumoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tatsuya Mikami, Ken Itoh, Chikara Ohyama
World Journal of Men's Health 2023.1
-
Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers
Kyo Togashi, Shingo Hatakeyama, Osamu Soma, Kazutaka Okita, Naoki Fujita, Toshikazu Tanaka, Daisuke Noro, Hirotaka Horiguchi, Nozomi Uemura, Takuro Iwane, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Cancers (Basel) 2022.12
-
Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction
Hikari Miura, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hirotaka Horiguchi, Ryuma Tanaka, Daisuke Noro, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic Oncology 2022.12
-
Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Tomoko Hamaya, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Andrology 2022.11
-
Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids
Noritaka Ishii, Shingo Hatakeyama, Tohru Yoneyama, Ryuma Tanaka, Takuma Narita, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic Oncology 2022.10
-
Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Scientific Reports 2022.8
-
Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
International Journal of Urology 2022.8
-
Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
Hiromichi Iwamura, Shingo Hatakeyama, Takuma Narita, Yusuke Ozaki, Sakae Konishi, Hirotaka Horiguchi, Hirotake Kodama, Yuta Kojima, Naoki Fujita, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Scientific Reports 2022.6
-
Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma
Kyo Togashi, Shingo Hatakeyama, Tohru Yoneyama, Tomoko Hamaya, Takuma Narita, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of urology 2022.6
-
Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients
Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama
Scientific Reports 2022.4
-
Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
The Aging Male 2021.12
-
Management of bladder cancer in older patients
Shingo Hatakeyama, Shintaro Narita, Kazutaka Okita, Takuma Narita, Hiromichi Iwamura, Naoki Fujita, Junichi Inokuchi, Yoshiyuki Matsui, Hiroshi Kitamura, Chikara Ohyama
Japanese journal of clinical oncology 2021.12
-
The cell surface hyaluronidase TMEM2 is essential for systemic hyaluronan catabolism and turnover
Yuki Tobisawa, Naoki Fujita, Hayato Yamamoto, Chikara Ohyama, Fumitoshi Irie, Yu Yamaguchi
The Journal of biological chemistry 2021.11
-
Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years
Kyo Togashi, Shingo Hatakeyama, Teppei Okamoto, Yuta Kojima, Hiromichi Iwamura, Naoki Fujita, Takuma Narita, Itsuto Hamano, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 2021.10
-
The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma
Kai Ozaki, Shingo Hatakeyama, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Hirotaka Horiguchi, Yoshiharu Okuyama, Naoki Fujita, Teppei Okamoto, Akiko Okamoto, Yuichiro Suzuki, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
BJUI Compass 2021.8
-
Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer
Yuki Miura, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hirotaka Horiguchi, Yoshiharu Okuyama, Yuta Kojima, Daisuke Noro, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
BJUI Compass 2021.8
-
The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma
Okita K, Hatakeyama S, Hagiwara K, Suzuki Y, Tanaka T, Noro D, Tokui N, Fujita N, Konishi S, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
2021.4
-
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer
Horiguchi H, Hatakeyama S, Yoneyama T, Yoneyama MS, Tanaka T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Yoshizawa T, Hashimoto Y, Kawaguchi T, Ohyama C
39 ( 4 ) 238.e9 - 238.e17 2021.4
-
Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study)
Kodama H, Hatakeyama S, Momota M, Togashi K, Hamaya T, Hamano I, Fujita N, Kojima Y, Okamoto T, Yoneyama T, Yamamoto H, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C
39 ( 3 ) 191.e1 - 191.e8 2021.3
-
Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy
Fujita N, Hatakeyama S, Okita K, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
39 ( 3 ) 191.e9 - 191.e16 2021.3
-
Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
39 ( 3 ) 194.e9 - 194.e16 2021.3
-
Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study)
Iwamura H, Hatakeyama S, Momota M, Kojima Y, Narita T, Okamoto T, Fujita N, Hamano I, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Translational andrology and urology 10 ( 3 ) 1143 - 1151 2021.3
-
The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study)
Togashi K, Hatakeyama S, Kojima Y, Momota M, Narita T, Iwamura H, Hamano I, Hamaya T, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
39 ( 3 ) 192.e7 - 192.e14 2021.3
-
Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study
Hamaya T, Hatakeyama S, Tanaka T, Kubota Y, Togashi K, Hosogoe S, Fujita N, Kusaka A, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C
2021.1
-
Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer
Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
39 ( 1 ) 75.e9 - 75.e16 2021.1
-
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study)
Hamaya T, Hatakeyama S, Momota M, Narita T, Iwamura H, Kojima Y, Hamano I, Fujita N, Okamoto T, Togashi K, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
26 ( 1 ) 199 - 206 2021.1
-
Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Mariya Y, Ohyama C
18 ( 5 ) e523 - e530 2020.10
-
Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
38 ( 10 ) 795.e9 - 795.e17 2020.10
-
Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer
Fujita N, Hatakeyama S, Momota M, Kido K, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
38 ( 8 ) 684.e17 - 684.e24 2020.8
-
Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer
Okita K, Hatakeyama S, Momota M, Soma O, Hamano I, Tanaka T, Iwamura H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Ohyama C
International journal of urology 27 ( 8 ) 649 - 654 2020.8
-
Geriatric 8 screening of frailty in patients with prostate cancer
Momota M, Hatakeyama S, Soma O, Tanaka T, Hamano I, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Imai A, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C
International journal of urology 27 ( 8 ) 642 - 648 2020.8
-
Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor
38 ( 8 ) 684.e1 - 684.e8 2020.8
-
The impact of microalbuminuria on overactive bladders: Results from a community-based four-year longitudinal study in Japan
Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Neurourology and urodynamics 2020.6
-
Relationship between frailty and lower urinary tract symptoms among community-dwelling adults
Soma O, Hatakeyama S, Imai A, Matsumoto T, Hamano I, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C
Lower urinary tract symptoms 12 ( 2 ) 128 - 136 2020.5
-
Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma
Suppanuntaroek S, Hatakeyama S, Fujita N, Kubota Y, Suzuki Y, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Mori K, Imai A, Yoneyama T, Hashimoto Y, Ohyama C
International journal of clinical oncology 25 ( 2 ) 362 - 369 2020.2
-
C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma
Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Hamano I, Fujita N, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C
International journal of urology 26 ( 10 ) 992 - 998 2019.10
-
Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers
Soma O, Hatakeyama S, Okamoto T, Fujita N, Hamano I, Tanaka T, Momota M, Yoneyama T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Saitoh H, Nakaji S, Suzuki T, Ohyama C
Medical oncology 36 ( 10 ) 88 2019.9
-
Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer
Kubota Y, Hatakeyama S, Hashimoto T, Fujita N, Okamoto T, Suzuki Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C
IJU case reports 2 ( 4 ) 236 - 239 2019.7
-
Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma
Kazutaka Okita, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Naoki Fujita, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama
Clinical genitourinary cancer 2019.6
-
Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma
Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
2018.12
-
Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer
Okita K, Hatakeyama S, Fujita N, Konishi S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Ito H, Yoshikawa K, Koie T, Ohyama C.
Medical Oncology 2018.11
-
Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis
Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C.
2018.11
-
Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution
Naoki Fujita, Takuya Koie, Yasuhiro Hashimoto, Takuma Narita, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Kazuhisa Hagiwara, Tohru Yoneyama, Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Chikara Ohyama
International urology and nephrology 2018.11
-
Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma
Koichi Kido, Shingo Hatakeyama, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama
International journal of clinical oncology 2018.8
-
Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers
Soma O, Hatakeyama S, Okamoto T, Fujita N, Matsumoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C
Oncotarget 9 ( 25 ) 17396 - 17405 2018.4
-
Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy
Horiguchi H, Yoneyama T, Hatakeyama S, Tokui N, Sato T, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Narita S, Kawaguchi T, Ohyama C
35 ( 4 ) 41 2018.2
-
Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava
Yoshimi Tanaka, Shingo Hatakeyama, Shogo Hosogoe, Toshikazu Tanaka, Itsuto Hamano, Ayumu Kusaka, Hiromich Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
International journal of clinical oncology 2018.2
-
Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution
Fujita N, Koie T, Ohyama C, Tanaka Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Tobisawa Y, Yoneyama T, Hatakeyama S, Hashimoto Y
International journal of clinical oncology 22 ( 6 ) 1087 - 1093 2017.12
-
Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study
Kubota Y, Hatakeyama S, Tanaka T, Fujita N, Iwamura H, Mikami J, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Ohyama C
Oncotarget 8 ( 60 ) 101500 - 101508 2017.11
-
Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma
Kodama H, Hatakeyama S, Fujita N, Iwamura H, Anan G, Fukushi K, Narita T, Tanaka T, Kubota Y, Horiguchi H, Momota M, Kido K, Matsumoto T, Soma O, Hamano I, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Sato M, Ohyama C
Oncotarget 8 ( 47 ) 83183 - 83194 2017.10
-
Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study
Go Anan, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Toshikazu Tanaka, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama
Oncotarget 2017.9
-
Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer
Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Hagiwara K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C
8 ( 39 ) 65492 - 65505 2017.9
-
Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer
Itsuto Hamano, Shingo Hatakeyama, Hiromichi Iwamurau, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Ayumu Kusaka, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama
2017.5
-
Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer
Medical oncology 2017.5
-
Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism
International journal of urology 2016.5
-
BCG菌株交替療法についての基礎的検討
盛 和行，飛澤悠葵，米山 徹，岩村大径，佐藤天童，藤田尚紀，三上穣太郎，今井 篤，畠山真吾，米山高弘，橋本安弘，古家琢也，大山 力
泌尿器外科 2016
-
ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘除術の治療成績
米山高弘，小島由太，佐藤天童，岩村大径，藤田尚紀，三上穣太郎，杉山尚樹，飛澤悠葵，米山 徹，今井 篤，畠山真吾，橋本安弘，古家琢也，大山 力
泌尿器外科 2015
-
Tubulocystic renal cell carcinoma in the left kidney: a case report
Journal of medical case reports 2014.7
-
Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy
The Scientific World Journal 2014.3
-
Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis
BMC Nephrology 2013.10
-
[Local recurrence of pheochromocytoma associated with von Hippel-Lindau disease 26 years after bilateral adrenalectomy : a case report].
Hinyokika kiyo. Acta urologica Japonica 59 ( 7 ) 427 - 30 2013.7
-
両側副腎褐色細胞腫摘除術26年後に局所再発した von Hippel-Lindau 病随伴褐色細胞腫の1例
藤田尚紀，三上穣太郎，村澤洋美，岡本亜希子，今井 篤，畠山真吾，石村大史，米山高弘，古家琢也，神村典孝，大山 力，諸橋聡子，鬼島 宏
泌尿器科紀要 2013
-
当科における整体腎移植ドナー腎再手術の検討
米山高弘，佐藤天童，藤田尚紀，小島由太，三上穣太郎，福士 謙，岩村大径，村澤洋美，飛澤悠葵，米山 徹，岡本亜希子，山本勇人，今井 篤，畠山真吾，盛 和行，橋本安弘，古家琢也，大山 力
腎移植・血管外科 2012
-
Advancements in Urology 2011 : A Japanese Urological Association (JUA)/American Urological Association (AUA) Symposium
NAITO Seiji, EGAWA Shin, NAKAGAWA Masayuki, KAKEHI Yoshiyuki, FLANIGAN Robert C, HAYASHI Tetsutaro, OHARA Shinya, TEISHIMA Jun, SHOJI Koichi, SENTANI Kazuhiro, OUE Naohide, YASUI Wataru, MATSUBARA Akio, SAKAMOTO Shinichi, KAWAMURA Koji, IMAMOTO Takashi, NIHEI Naoki, KYPRIANOU Natasha, ICHIKAWA Tomohiko, HASHIMOTO Kohei, MASUMORI Naoya, TANAKA Toshiaki, KITAMURA Hiroshi, TSUKAMOTO Taiji, KIMURA Kyosuke, TSUKII Toyonori, KAMIHIRA Osanu, SASSA Naoto, KOMATSU Tomonori, HATTORI Ryohei, GOTOH Momokazu, SHIMIZU Shinjiro, JO Yoshimasa, YOKOYAMA Teruhiko, KAIFU Mikako, HARA Ryoei, FUJII Tomohiro, MIYAJI Yoshiyuki, NAGAI Atsushi, TSUZUKI Shunsuke, KIDO Masahito, YAMAMOTO Toshihiro, MIKI Jun, KIMURA Takahiro, MIKI Kenta, AOKI Manabu, EGAWA Shin, NAKANISHI Juro, WADA Yoshihiro, TAKAHASHI Wataru, HONDA Jiro, ETO Masatoshi, KITAGAWA Yasuhide, SHIGEHARA Kazuyoshi, MIWA Sotaro, MIYAGI Toru, KADONO Yoshifumi, KONAKA Hiroyuki, MIZOKAMI Atsushi, NAMIKI Mikio, KATO Takuma, YANO Toshifumi, HIRAMA Hiromi, UETSUKI Hiotsugu, TSUNEMORI Hiroyuki, INUI Masashi, SUGIMOTO Mikio, KAKEHI Yoshiyuki, ICHIMATSU Keisuke, IIDA Hiroaki, MORII Akihiro, YASUDA Kenji, WATANABE Akihiko, NOZAKI Tetsuo, KOMIYA Akira, FUSE Hideki, MAKI Yoshio, KURUMA Hidetoshi, GUST Kilian, MATSUMOTO Hiroaki, ZOUBEIDI Amina, FAZLI Ladan, LODDICK Sarah, BROOKS Nigel, GLEAVE Martin, CHOI Han Y, PARK Jong W, PARK Seo Y, LEE Hyun M, JEON Seong S, SEO Seong I, PARK Byung K, HIRAI Kenichi, NOMURA Takeo, YAMASAKI Mutsushi, MATSUBARA Takanori, SATO Fuminori, MIMATA Hiromitsu, SENO Yasuyuki, KATO Masao, MITA Koji, NOMURA Takeo, HUANG Wen-Chin, CHUNG Leland WK, MIMATA Hiromitsu, MURAKAMI Masaya, MIKI Jun, KIMURA Takahiro, HATANO Takashi, EGAWA Shin, MATSUTA Yosuke, AKINO Hironobu, NAMIKI Mikio, FUSE Hideki, SUZUKI Kouji, YOKOYAMA Osamu, ONIZUKA Chie, KAMIMURA Toshio, NAGANO Masafumi, YAMAGUCHI Takanori, KAMOTO Toshiyuki, HASHIMOTO Jiro, TAKAHASHI Satoshi, UEHARA Teruhisa, KURIMURA Yuichiro, TSUKAMOTO Taiji, FUKUMOTO Kazuhiko, YOKOYAMA Teruhiko, KAIFU Mikako, HARA Ryoei, FUJII Tomohiro, JO Yoshimasa, MIYAJI Yoshiyuki, NAGAI Atsushi, TORIMOTO Kazumasa, TAKAMI Takeshi, HIRAYAMA Akihide, KUWADA Masaomi, KAGEBAYASHI Yoriaki, SAMMA Shoji, FUJIMOTO Kiyohide, HIRAO Yoshihiko, ISHIURA Yoshiyuki, YAEGASHI Hiroshi, KOSHIDA Kiyoshi, MAEDA Yoshiko, SEKIGUCHI Yuki, SHITAMURA Takahiro, INOUE Katumi, NOSE Kiyotaka, KAMOTO Toshiyuki, HAYAMI Hiroshi, ENOKIDA Hideki, NAKAGAWA Masayuki, NAITO Seiji, MATSUMOTO Tetsuro, UOZUMI Jiro, MIMATA Hiromitsu, TAKEI Mineo, YOKOYAMA Teruhiko, FUKUMOTO Kazuhiko, HARA Ryoei, FUJII Tomohiro, JO Yoshimasa, MIYAJI Yoshiyuki, NAGAI Atsushi, KAMIMURA Noritaka, FUJITA Naoki, TOKUI Noriko, OKAMOTO Teppei, IMANISHI Kengo, SUGIYAMA Naoki, IMAI Atsushi, OHYAMA Chikara, YOSHINO Hirofumi, CHIYOMARU Takeshi, ENOKIDA Hideki, KAWAKAMI Kazumori, TATARANO Shuichi, NISHIYAMA Kenryu, SEKI Naohiko, NAKAGAWA Masayuki, TATARANO Shuichi, CHIYOMARU Takeshi, KAWAKAMI Kazumori, ENOKIDA Hideki, YOSHINO Hirofumi, NISHIYAMA Kenryu, SEKI Naohiko, NAKAGAWA Masayuki, SEGAWA Takehiko, TAKAHASHI Takeshi, MATSUMOTO Keiyu, SUMIYOSHI Takayuki, UTSUNOMIYA Noriaki, MUGURUMA Koei, KAWAKITA Mutsushi, IKEDA Hiroshi, NOMURA Masayoshi, SHOU Takehiko, ISHIKAWA Kaori, KASHIWAGI Eiji, DEJIMA Takashi, SANEFUJI Hayato, OKUMURA Kouji, YANAGISAWA Takafumi, MIKI Jun, ISHII Gen, BANDO Shigehiro, MIKI Kenta, EGAWA Shin, TANAKA Nobuyuki, KIKUCHI Eiji, MATSUMOTO Kazuhiro, MIYAJIMA Akira, NAKAGAWA Ken, OYA Mototsugu, ISHII Gen, MIKI Jun, TABATA Ryuji, KIMURA Takahiro, EGAWA Shin, KAWAMURA Koji, SAKAMOTO Shinichi, UTSUMI Takanobu, IMAMOTO Takashi, NIHEI Naoki, ICHIKAWA Tomohiko
International journal of urology 18 ( 5 ) 388 - 408 2011.5